APA

Ducreux M., Dahan L., Smith D., O'Toole D., Lepère C., Dromain C., Vilgrain V., Baudin E., Lombard-Bohas C., Scoazec J., Seitz J., Bitoun L., Koné S. & Mitry E. (20150127). Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial. : European journal of cancer (Oxford, England : 1990).

Chicago

Ducreux Michel, Dahan Laetitia, Smith Denis, O'Toole Dermot, Lepère Céline, Dromain Clarisse, Vilgrain Valérie, Baudin Eric, Lombard-Bohas Catherine, Scoazec Jean-Yves, Seitz Jean-François, Bitoun Laurence, Koné Sébastien and Mitry Emmanuel. 20150127. Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial. : European journal of cancer (Oxford, England : 1990).

Harvard

Ducreux M., Dahan L., Smith D., O'Toole D., Lepère C., Dromain C., Vilgrain V., Baudin E., Lombard-Bohas C., Scoazec J., Seitz J., Bitoun L., Koné S. and Mitry E. (20150127). Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial. : European journal of cancer (Oxford, England : 1990).

MLA

Ducreux Michel, Dahan Laetitia, Smith Denis, O'Toole Dermot, Lepère Céline, Dromain Clarisse, Vilgrain Valérie, Baudin Eric, Lombard-Bohas Catherine, Scoazec Jean-Yves, Seitz Jean-François, Bitoun Laurence, Koné Sébastien and Mitry Emmanuel. Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial)--a phase II non-randomised trial. : European journal of cancer (Oxford, England : 1990). 20150127.